Assessment of myocardial blood volume and water exchange: theoretical considerations and in vivo results.
The measured signal response in contrast-enhanced myocardial perfusion imaging has been shown to be affected by the rate of water exchange between the intravascular and extravascular compartments, the effect being particularly significant when intravascular contrast agents are used. In the present study, the T(1) relaxation rates were measured in eight pigs in blood and myocardium using a Look-Locker sequence after repeated injections of the intravascular contrast agent NC100150. The selection of myocardial region of interest was automated based on a minimum chi-square method. The intra- and extravascular water exchange rates and the myocardial blood volume were calculated from the measured relaxation rates by applying a two-compartment water exchange limited model that accounts for biexponential longitudinal relaxation. The following (mean +/- SD) values were obtained for the exchange frequency (f), the extravascular residence time (tau(e)), the intravascular residence time (tau(i)) and blood volume (BV), respectively: f = 1.39 +/- 0.52 s(-1), tau(e) = 708 +/- 264 ms, tau(i) = 107 +/- 63 ms, and BV = 11.2 +/- 2.1 mL/100 g. The mean value of f was found to be about 15% higher if biexponential relaxation was not accounted for, supporting the hypothesis that significant biexponential relaxation in tissues with large blood volume can lead to an overestimation of water exchange rates unless corrected for.
Bjørnerud
Atle
A
Department of Diagnostic Radiology, Uppsala University Hospital, Uppsala, Sweden. atle.bjornerud@rikshospitalet.no
Bjerner
Tomas
T
Johansson
Lars O
LO
Ahlström
Håkan K
HK
D000818:Animals; D001810:Blood Volume / Q000502:physiology*; D001834:Body Water / Q000502:physiology*; D003198:Computer Simulation; D003287:Contrast Media / Q000008:administration & dosage; D003911:Dextrans; D005260:Female; D052203:Ferrosoferric Oxide; D006321:Heart / Q000502:physiology*; D007089:Image Enhancement; D007267:Injections; D007501:Iron / Q000008:administration & dosage; D008279:Magnetic Resonance Imaging; D058185:Magnetite Nanoparticles; D008297:Male; D023421:Models, Animal; D008955:Models, Cardiovascular; D009010:Monte Carlo Method; D009206:Myocardium; D010087:Oxides / Q000008:administration & dosage; D012044:Regression Analysis; D013552:Swine
D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D010087:Oxides; C097921:ferumoxtran-10; D007501:Iron; D052203:Ferrosoferric Oxide